A U.S. patent was issued on Dec 18, 2018 to Rory A. Fisher, Adele Stewart, Biswanath Maity, Christopher Bodle and David Roman entitled “Treating Alcohol-mediated Disorders by Inhibition of RGS6.”  This patent includes a method for ameliorating or alleviating the effects of ethanol consumption in an individual in need of treatment by administering an inhibitor of RGS6.  The method in this claim is to be used to ameliorate or alleviate ethanol craving and/or withdrawal, as well as ethanol mediated organ damage to the heart, liver and gastrointestinal tract.